Company Overview of T-19 Inc
T-19 Inc manufactures and markets pharmaceutical products. The company's flagship product TUBERCIN is an immunostimulant that strengthens the human body's own immune system and assists the body in seeking out and combating cancer cells. The company is based in Honolulu, Hawaii. T-19 Inc is a former subsidiary of Hard to Treat Diseases Inc. Prior to Reverse Merger with Shenzhen Mellow Hope Pharm Industrial Co.
Key Executives for T-19 Inc
T-19 Inc does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact T-19 Inc, please visit www.t-19.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.